✦ LIBER ✦

P-597 Efficacy and predictive marker of gefitinib in pretreated Chinesepatients with advanced NSCLC

✍ Scribed by Zhang, X.; Li, L.; Mu, X.; Wamg, S.; Cui, Q.; Wang, M.; Zhong, W.; Zhang, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of gefitinib i

✍ Cappuzzo, F; Bartolini, S; Ceresoli, G L; Tamberi, S; Spreafico, A; Lombardo, L; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

P-12 Survival in advanced NSCLC and pret

✍ Baekke, Janne; Sindrup, Hanne; Oleson, Rene; Palshof, Torben; Rytter, Carsten; H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 360 KB

P-955 Clinicopathological features and e

✍ Kawano, Y.; Kashii, T.; Katayama, H.; Hasegawa, Y.; Tokunaga, S.; Sumitani, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Efficacy and safety of vinorelbine in el

✍ Mattioli, R; Imperatori, L; Casdei, V; Guidi, F; Gattafoni, P; Paggi, P; Lonardo 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 133 KB

607 NCIC CTG IND.196: Phase I Study of F

✍ Leighl, N.B.; Tsao, M.S.; Ho, C.; Shepherd, F.A.; Murray, N.; Goffin, J.; Nichol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Can mutations of EGFR and KRAS in serum

✍ Seung Tae Kim, Jae Sook Sung, Uk Hyun Jo, Kyong Hwa Park, Sang Won Shin, Yeul Ho 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 300 KB